Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2000
12/14/2000WO2000075158A2 NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000WO2000075120A1 Diaminothiazoles and their use for inhibiting protein kinases
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074745A1 Drug releasing elastic band and method
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074721A1 Vitamin directed dual targeting therapy
12/14/2000WO2000074719A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074711A2 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074693A2 Immunity generation
12/14/2000WO2000074683A1 Antitumor effect potentiators
12/14/2000WO2000074682A1 Thrombin inhibitors
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074670A1 USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON β-GLUCURONIDASE IN HUMAN TISSUE
12/14/2000WO2000074667A2 Compositions active in telomere damage comprising a taxane and telomerase inhibitor
12/14/2000WO2000074658A1 Use of drug-loaded nanoparticles for the treatment of cancers
12/14/2000WO2000074646A2 Novel liposomal vector complexes and their use in gene therapy
12/14/2000WO2000074634A2 Methods and compositions for modulating cell proliferation and cell death
12/14/2000WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000WO2000074485A1 Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors
12/14/2000WO2000054049A3 Determination of the chemosensitivity via the caspase activity
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000046187A3 Antizyme modulators and their use
12/14/2000WO2000045841A3 Human papilloma virus vaccine formulations
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000DE19926154A1 Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung A process for producing an injectable medicament preparation
12/14/2000DE19925810A1 Anwendung von Verapamil und Verapamilderivaten zur Herstellung von Arzneimitteln mit Glucuronidase hemmender Wirkung Application of verapamil and Verapamilderivaten for producing drugs with glucuronidase inhibiting action
12/14/2000CA2390948A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2378735A1 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000CA2377385A1 Methods and compositions for modulating cell proliferation and cell death
12/14/2000CA2376939A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376199A1 Use of verapamil and verapamil derivatives for producing medicaments with an inhibiting effect on .beta.-glucuronidase in human tissue
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376179A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
12/14/2000CA2376175A1 Vitamin directed dual targeting therapy
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2376010A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2375854A1 Novel liposomal vector complexes and their use in gene therapy
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375149A1 Apo-2l receptor agonist and cpt-11 synergism
12/14/2000CA2375145A1 Substrate trapping protein tyrosine phosphatases
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374654A1 Thrombin inhibitors
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy
12/14/2000CA2373336A1 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000CA2373277A1 Immunity generation
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2371158A1 Diaminothiazoles and their use for inhibiting protein kinases
12/14/2000CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000CA2337853A1 Drug releasing elastomeric ligating band
12/13/2000EP1059086A1 Use of sandal wood oil or constituents of sandal wood oil for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
12/13/2000EP1058725A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same
12/13/2000EP1058686A1 2'-fluoronucleosides
12/13/2000EP1058683A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/13/2000EP1058679A1 Synthesis of epothilones, intermediates thereto and analogues therof
12/13/2000EP1058562A1 Compositions and methods of treating tumors
12/13/2000EP1058545A1 Cancer management with tamoxifen and gammalinolenic acid
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0725641B1 NOVEL INHIBITORS OF URIDINE PHOSPHORYLASE (UrdPase) AND DIHYDROURACIL DEHYDROGENASE (DHUDase)
12/13/2000CN1276833A Vaccine
12/13/2000CN1276832A Composition and method for identifying PKB kinase inhibitors
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276791A Macrolides with antitumor activity
12/13/2000CN1276789A 4-aminothiazole derivs, their preparation and their use as inhibitors of cyclin-dependent kinases
12/13/2000CN1276723A Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agent
12/13/2000CN1276720A Formulations and method for reducing toxicity of antineoplastic agent
12/13/2000CN1276428A Clone and expression of anti-CA125 bifunctional genetically engineered antibody
12/13/2000CN1276379A Polypeptide-thyrocalcitonin 11 and polynucleotide for coding same
1 ... 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 ... 2211